Inhibition of VEGF expression through blockade of Hif1α and STAT3 signalling mediates the anti-angiogenic effect of melatonin in HepG2 liver cancer cells-Reference-Cited by-同舟云学术

Inhibition of VEGF expression through blockade of Hif1α and STAT3 signalling mediates the anti-angiogenic effect of melatonin in HepG2 liver cancer cells

Published:2013-06-11 Issue:1 Volume:109 Page:83-91
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Carbajo-Pescador S,Ordoñez R,Benet M,Jover R,García-Palomo A,Mauriz J L,González-Gallego J

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc2013285.pdf

Reference62 articles.

1. Albini A, Tosetti F, Li VW, Noonan DM, Li WW (2012) Cancer prevention by targeting angiogenesis. Nat Rev Clin Oncol 9: 498–509.

2. Alvarez-Garcia V, Gonzalez A, Alonso-Gonzalez C, Martinez-Campa C, Cos S (2012) Regulation of vascular endothelial growth factor by melatonin in human breast cancer cells. J Pineal Res 54: 373–380.

3. Alvarez-Garcia V, Gonzalez A, Alonso-Gonzalez C, Martinez-Campa C, Cos S (2013) Antiangiogenic effects of melatonin in endothelial cell cultures. Microvasc Res 87: 25–33.

4. Bansal A (2009) Molecular mechanisms of acclimatization to high altitude hypoxia: role of hypoxia mimetic cobalt chloride. DRDO Science Spectrum 1: 172–179.

5. Benet M, Lahoz A, Guzman C, Castell JV, Jover R (2010) CCAAT/enhancer-binding protein alpha (C/EBPalpha) and hepatocyte nuclear factor 4alpha (HNF4alpha) synergistically cooperate with constitutive androstane receptor to transactivate the human cytochrome P450 2B6 (CYP2B6) gene: application to the development of a metabolically competent human hepatic cell model. J Biol Chem 285: 28457–28471.

Cited by 212 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nature’s Elixir for Cancer Treatment: Targeting Tumor-induced Neovascularization;Current Medicinal Chemistry;2024-10

2. Reserpine, a novel N6-methyladenosine regulator, reverses Lenvatinib resistance in hepatocellular carcinoma;Phytomedicine;2024-09

3. Autophagy modulation attenuates sorafenib resistance in HCC induced in rats;Cell Death & Disease;2024-08-16

4. Combined neurokinin-1 receptor antagonist and sorafenib is a promising approach for hepatocellular carcinoma therapy;Egyptian Liver Journal;2024-07-12

5. Aclarubicin: contemporary insights into its mechanism of action, toxicity, pharmacokinetics, and clinical standing;Cancer Chemotherapy and Pharmacology;2024-07-04